InsiderTrades

Form 4 for LXFR LUXFER HOLDINGS PLC

Accepted 2025-05-22 00:00:00 ET · period of report 2025-05-20 · accession 0001761477-25-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-05-22 2025-05-20 LXFR Wardlow Graham See Remarks S - Sale+OE $11.95 -4,874 33.8K -13% -$58.2K
DM 2025-05-22 2025-05-20 LXFR Wardlow Graham See Remarks M - OptEx — +9,675 38.7K +33% —
DM 2025-05-22 2025-05-20 LXFR Wardlow Graham See Remarks M - OptEx $11.95 -9,675 0 -100% -$115.6K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2025-05-20 S D 4,874 $11.95 33,809 D — —
2 Common Ordinary Shares 2025-05-20 M A 928 — 29,936 D — — (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
3 Common Ordinary Shares 2025-05-20 M A 1,128 — 31,064 D — — (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
4 Common Ordinary Shares 2025-05-20 M A 1,250 — 32,314 D — — (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
5 Common Ordinary Shares 2025-05-20 M A 1,885 — 34,199 D — — (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
6 Common Ordinary Shares 2025-05-20 M A 1,280 — 35,479 D — — (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
7 Common Ordinary Shares 2025-05-20 M A 2,304 — 37,783 D — — (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
8 Common Ordinary Shares 2025-05-20 M A 900 — 38,683 D — — (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
9 Derivative Stock Options (Right to Buy) 2025-05-20 M D 928 $11.95 0 D — · — to 2027-03-15 928 Ordinary Shares (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. (F2) Represents the exercise of time-based Stock Options awarded on March 15, 2021. The subject Stock Options vested and were exercisable as of March 15, 2025.
10 Derivative Stock Options (Right to Buy) 2025-05-20 M D 1,128 $11.95 1,000 D — · — to 2028-03-14 1,128 Ordinary Shares (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. (F3) Represents the exercise of time-based Stock Options awarded on March 14, 2022. The subject Stock Options vested and were exercisable as of March 14, 2025. The remaining Stock Options vest and become exercisable on March 14, 2026.
11 Derivative Stock Options (Right to Buy) 2025-05-20 M D 1,250 $11.95 2,300 D — · — to 2029-03-20 1,250 Ordinary Shares (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. (F4) Represents the exercise of time-based Stock Options awarded on March 20, 2023. The subject Stock Options vested and were exercisable as of March 20, 2025. The remaining Stock Options vest in two equal annual installments beginning on March 20, 2026
12 Derivative Stock Options (Right to Buy) 2025-05-20 M D 1,885 $11.95 5,430 D — · — to 2030-03-18 1,885 Ordinary Shares (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. (F5) Represents the exercise of time-based Stock Options awarded on March 18, 2024. The subject Stock Options vested and were exercisable as of March 18, 2025. The remaining Stock Options vest in three equal annual installments beginning on March 18, 2026.
13 Derivative Stock Options (Right to Buy) 2025-05-20 M D 1,280 $11.95 0 D — · — to 2027-03-15 1,280 Ordinary Shares (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. (F6) Represents the grant of performance-based Stock Options (at 200% target) upon the achievement of an adjusted diluted EPS performance metric for the performance period ended December 31, 2021. One-third of the performance-based Stock Options, being 1,280 Stock Options, vested on March 15, 2023., March 15, 2024 and March15, 2025.
14 Derivative Stock Options (Right to Buy) 2025-05-20 M D 2,304 $11.95 0 D — · — to 2027-03-14 2,304 Ordinary Shares (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. (F7) Represents the grant and full vesting of performance-based Stock Options (at 96% target) awarded on March 14, 2022. 100% of the performance-based Stock Options vested on March 14, 2025 upon the achievement of Earnings Per Share (EPS) Growth goals for the three-year performance period ended December 31, 2024.
15 Derivative Stock Options (Right to Buy) 2025-05-20 M D 900 $11.95 0 D — · — to 2027-03-14 900 Ordinary Shares (F1) 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share. (F8) Represents the grant and full vesting of performance-based Stock Options (at 25% target) awarded on March 14, 2022. 100% of the performance-based Stock Options vested on March 14, 2025 upon the achievement of Total Shareholder Return (TSR) goals for the three-year performance period ended December 31, 2024.